Showing results (321-330 of 351) with videos related to
Sort By:
Pageof 36
Journal of Affective Disorders|September 5, 2024
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK studyGiacomo d'Andrea, Andrea Miuli, Mauro Pettorruso, et al.Heliyon|March 21, 2024
Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer's diseaseMiriam Punzi, Carlo Sestieri, Eleonora Picerni, et al.Ageing Research Reviews|June 3, 2024
Donanemab, another anti-Alzheimer's drug with risk and uncertain benefitPoul F Høilund-Carlsen, Abass Alavi, Jorge R Barrio, et al.Frontiers in Neurology|September 14, 2020
Interictal Heart Rate Variability Analysis Reveals Lateralization of Cardiac Autonomic Control in Temporal Lobe EpilepsyFedele Dono, Giacomo Evangelista, Valerio Frazzini, et al.Seizure|May 9, 2022
Perampanel enhances the cardiovagal tone and heart rate variability (HRV) in patients with drug-resistant temporal lobe epilepsyFedele Dono, Giacomo Evangelista, Stefano Consoli, et al.Ageing Research Reviews|December 17, 2023
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin villagePoul F Høilund-Carlsen, Abass Alavi, Jorge R Barrio, et al.Translational Psychiatry|June 24, 2026
Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careMauro Pettorruso, Giacomo d'Andrea, Antonio Inserra, et al.Translational Psychiatry|November 1, 2025
Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changesGiacomo d'Andrea, Stefania Chiappini, Laura Ciavoni, et al.European Journal of Neurology|May 8, 2023
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imagingDaniele Mascali, Alessandro Villani, Antonio M Chiarelli, et al.Ageing Research Reviews|April 29, 2026
Serious Side Effects of Alzheimer's Immunotherapy Demand ScrutinyPoul F Høilund-Carlsen, Abass Alavi, Sasan Andalib, et al.Pageof 36